Interesting medical article on cancelling the spike protein.

[seahawks2884]

"Practically speaking, it does not matter whether an adverse event that occurs after a vaccination gets "blamed" on the vaccination. Such a matter may never get resolved. The issue of greatest concern is whether that adverse event can be clinically resolved if not effectively prevented, and whether any long-term damage to the body can be prevented once an adverse event is recognized. The remainder of this article will address the etiologies of such damage along with measures that can mitigate or even resolve such damage."
"This article does not seek to clarify this issue to the satisfaction of either the pro-vaccine or the anti-vaccine advocates."
Neutral.
"When antioxidants can donate electrons back to oxidized biomolecules (reduction), the normal function of these biomolecules is restored."
http://orthomolecular.org/resources/omns/v17n24.shtml
My seven cents.......

[Silverstarqueen]

Review of 99 studies: Thrombosis due to vaccine is rare.
"4.7. How concerning are the cardiovascular and hematological events post‐COVID‐19 vaccination?
In order to answer this question, it is essential to evaluate the rate of incidence of such events following COVID‐19 vaccination. One limitation was that most of the included studies were either case series or case reports. It was, therefore, difficult to calculate the prevalence of the CV and haematological events among the vaccinated populations. However, it was possible to calculate the prevalence of the CI and thrombotic events from five population studies. For example, Pawlowski et al. 24 reported that out of 132913 individuals who received the Pfizer vaccine, only three (0.002%) experienced thrombosis. Pottegård et al. reported that 0.0002% of 281264 individuals who received the AstraZeneca vaccine suffered from CI while 0.04% suffered from thrombosis. Similarly, Tobaiqy et al. 61 reported 41 thrombotic events out of 54571 adverse events reported to the EU database. This means that thrombosis represented 0.075% of the reported adverse events following AstraZeneca vaccination. However, the number of individuals who received at least one dose of the AstraZeneca vaccine in the UK and EU was 17,000,000, suggesting a low prevalence of thrombosis following COVID‐19 vaccination (0.00024%). Sørvoll et al. 93 reported that 1.62% of 492 people who received the AstraZeneca vaccine had TP. Finally, Smadja et al. reported a very low rate (0.0006% of 361734967) of thrombosis post Pfizer, Moderna and AstraZeneca vaccination. According to the National Health Service (NHS), UK 137 the incidence of thrombosis after the second dose of AstraZeneca vaccination in the UK is 1.3 per million doses, and all cases were in patients aged 50 years or older.

In addition to the rarity of such events, it is important to understand that COVID‐19 itself may cause CI and thrombosis. 114 , 138 Furthermore, the rate of such severe events is much higher when associated with COVID‐19 than the rate of vaccine‐induced CI and thrombosis"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817142/

I can't find anything in the way of studies on covid or covid vaccines by Levy.